![Gary Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Gary Lee
Directeur Technique/Scientifique/R&D chez
LYELL IMMUNOPHARMA, INC.
Fortune : 232 270 $ au 31/08/2026
Profil
Gary Lee is currently Chief Scientific Officer at Lyell Immunopharma, Inc. since 2022.
Formerly, Dr. Lee was Vice President-Cell Therapy at Sangamo Therapeutics, Inc. from 2005 to 2018 and Chief Scientific Officer at Senti Sub I, Inc. from 2018 to 2022.
Education includes undergraduate studies at California Institute of Technology and a doctorate from the University of California, Berkeley.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LYELL IMMUNOPHARMA, INC. 0,07 % | 21/08/2026 | 16 220 ( 0,07 % ) | 232 270 $ | 31/08/2026 |
Postes actifs de Gary Lee
| Sociétés | Poste | Début |
|---|---|---|
| LYELL IMMUNOPHARMA, INC. | Directeur Technique/Scientifique/R&D | 31/01/2022 |
Anciens postes connus de Gary Lee
| Sociétés | Poste | Fin |
|---|---|---|
Senti Sub I, Inc.
 Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Directeur Technique/Scientifique/R&D | 01/01/2022 |
| SANGAMO THERAPEUTICS, INC. | Corporate Officer/Principal | 01/10/2018 |
Formation de Gary Lee
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
63
Relations au 1er degré
5
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Sangamo Therapeutics, Inc.
 Sangamo Therapeutics, Inc. BiotechnologyHealth Technology Operates as a genomic medicine company | Health Technology |
California Institute of Technology
 California Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Senti Sub I, Inc.
Senti Sub I, Inc. BiotechnologyHealth Technology Develops novel therapeutics | Health Technology |
Lyell Immunopharma, Inc.
 Lyell Immunopharma, Inc. BiotechnologyHealth Technology Develops cell-based immunotherapies for human diseases | Health Technology |
